Table II.
Comparisons of PET/CT1 SUVmax, PET/CT2 SUVmax, ΔSUVmax and ΔSUVmax% between OR and non-OR groups.
| Groups | N | Mean ± standard deviation | P-value | 95% CI |
|---|---|---|---|---|
| PET/CT1 SUVmax | 0.5484 | −1.370–2.510 | ||
| OR | 12 | 7.128±0.654 | ||
| Non-OR | 12 | 6.558±0.668 | ||
| PET/CT2 SUVmax | 0.0655 | −3.519–0.119 | ||
| OR | 12 | 4.398±0.581 | ||
| Non-OR | 12 | 6.098±0.657 | ||
| ΔSUVmax | 0.0001 | 1.266–3.274 | ||
| OR | 12 | 2.730±0.241 | ||
| Non-OR | 12 | 0.460±0.420 | ||
| ΔSUVmax% | 0.0004 | 19.380–55.750 | ||
| OR | 12 | 41.190±4.318 | ||
| Non-OR | 12 | 3.622±7.633 |
PET/CT1, positron emission tomography-computed tomography prior to chemotherapy; PET/CT2, positron emission tomography-computed tomography following chemotherapy; SUVmax, maximal standardized uptake value; OR, objective remission; CI, confidence interval.